Labcorp Expands Diagnostic Integration with Epic's Aura Platform
Labcorp has expanded its collaboration with Epic Systems Corporation, announced in a press release. The partnership will make Labcorp’s entire test menu accessible through Epic’s Aura platform, enabling hospitals and health systems using Epic to order and receive lab results directly within their existing workflows.
The integration builds on the earlier deployment of Invitae genetic testing through Aura. It aims to reduce IT complexity, shorten integration timelines, and lower maintenance costs for health systems. By connecting through Aura, clinicians can access Labcorp’s full range of diagnostic tests and new offerings as they become available.
Epic stated that expanding Labcorp’s use of Aura will allow clinicians to order appropriate tests more efficiently and receive results faster. Labcorp noted that the collaboration supports its goal of simplifying lab integrations and improving access to diagnostic innovation across Epic’s network of healthcare organizations.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Oct 16 McGraw Hill Adds AI Study Tools to Connect Oct 16 RapidCanvas Raises $29 Million to Expand Enterprise AI Platform Oct 16 Goodweek Raises $12 Million for AI Management Platform Oct 16 ALTOUR Unveils AI Platform for Corporate Travel Decisions Oct 16 BOC Group Adds AI Assistant to ADOIT 21More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Lunit and Discovery Life Sciences Partner on AI Tissue Analysis
Assort Health and Nextech to Build AI Agent for Ophthalmology Practices
Domino Data Lab and EPAM Partner on Validated AI for Life Sciences
ARUP Selected for Redtail Clinical AI Project
PhyPal Relaunches Patient Engagement Platform With Conversational AI
Daily AI Brief: the AI news that matters, in your inbox.